Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An efficient method for removing bilirubin.

D R Miles1, W J Dorson, T A Brandon

  • 1Department of Chemical, Bio, and Materials Engineering, Arizona State University, Tempe 85287.

ASAIO Transactions
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal multispectral and 3D analysis of Cerro de Pasco, Peru.

The Science of the total environment·2019
Same author

Optical properties of normal and diseased breast tissues: prognosis for optical mammography.

Journal of biomedical optics·2012
Same author

Hair analysis versus conventional methods of drug testing in substance abusers seeking organ transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Multicenter study to assess potential hazards from exposure to lipid peroxidation products in soya bean oil from Trilucent breast implants.

Regulatory toxicology and pharmacology : RTP·2008
Same author

Point fingerprint: a new 3-D object representation scheme.

IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society·2008
Same author

Population pharmacokinetics and bioavailability of motexafin gadolinium (Xcytrin) in CD1 mice following intravenous and intraperitoneal injection.

Investigational new drugs·2006
Same journal

Extracorporeal membrane oxygenation as a means of stabilizing and transporting high risk neonates.

ASAIO transactions·1991
Same journal

Pumping capabilities of the latissimus dorsi and rectus abdominis muscles wrapped around a valved pouch in a mock circulatory system.

ASAIO transactions·1991
Same journal

Causes of intraaortic balloon leaks.

ASAIO transactions·1991
Same journal

Influence of centrifugal blood pumps on the elasticity of erythrocytes.

ASAIO transactions·1991
Same journal

Reuse of "highly permeable" dialyzers with peroxyacetic acid as sole cleansing and disinfecting agent.

ASAIO transactions·1991
Same journal

Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps.

ASAIO transactions·1991
See all related articles

Adding a safe unbinding agent, sodium benzoate, to hemoperfusion significantly enhances bilirubin removal in hyperbilirubinemic canines. This approach makes hemoperfusion a more effective treatment for high bilirubin levels.

Area of Science:

  • Biomedical Engineering
  • Toxicology
  • Clinical Chemistry

Background:

  • Bilirubin's tight binding to albumin limits hemoperfusion efficacy for hyperbilirubinemia.
  • Developing effective hemoperfusion strategies requires addressing bilirubin's albumin binding.

Purpose of the Study:

  • To evaluate the efficacy of a solutizer (sodium benzoate) in enhancing hemoperfusion for hyperbilirubinemia.
  • To assess the impact of sodium benzoate on bilirubin reduction and platelet protection during hemoperfusion.

Main Methods:

  • Canine models were induced with hyperbilirubinemia via intravenous infusion.
  • Hemoperfusion was performed with and without sodium benzoate (solutizer).
  • Activated carbon pre-saturated with sodium benzoate was used, alongside continuous infusion.

Related Experiment Videos

Main Results:

  • Sodium benzoate rapidly and effectively unbound bilirubin.
  • Benzoate-augmented hemoperfusion reduced normalized bilirubin concentration threefold compared to controls after 1.5 hours.
  • Sodium benzoate demonstrated potential for platelet protection during hemoperfusion.

Conclusions:

  • Sodium benzoate significantly improves hemoperfusion efficiency for treating hyperbilirubinemia.
  • This solutizer-enhanced hemoperfusion offers a practical and effective approach to managing high bilirubin levels.
  • Sodium benzoate may provide an added benefit of platelet preservation.